Sunday, February 21, 2016

The smoothie of Green Tea, Carrot and Almondfor reduced Risk and Treatment of Retinitis pigmentosa back by Respectable Institutions

Kyle J. Norton(Scholar, Master of Nutrients), all right reserved.
Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.

The smoothie for reduced risk and Treatment of Retinitis pigmentosa
Yield: 2 serving (about 8 ounce each)
1 cup olive juice or 1 1/2 cups of olive
1 tsp of curcumin
1 cup green tea drink (Make from 4 grams of green tea, and a cup of hot water lipped for 5 minutes. Set aside for cooling to room temperature)

1. Place all ingredients in a blender and puree about 1 minute
2. Blend on high speed about 1 minute or until the mixture is thick and the ice is well crushed. Add more green tea drink if needed
3. Serve immediately

The finding the natural ingredients for treatment of Retinitis pigmentosa  is considered as a dream of many scientist to replace the long term usage adverse effect of conventional medicine to other organs in the body. Unfortunately, many compounds found effective in initial studying failed to confirm the potential in large sample size and multi center.

Retinitis pigmentosa is an genetic degenerate eye disease, damaged to the retina of that can lead to severe vision impairment and blindness.
Recent studies suggested that scientist in some research centers have found the naturally potential ingredients, such as Carrot(1), green tea(3) and Almond(7) for reduced risk and treatment for
Eczema.

Carrot is root vegetable with orange color normally, a sub spices of Daucus carota, belongings to the family Apiaceae, native to Asian and Europe. Its vitamin A, a nutritional intake showed to modify the rate of decline of visual acuity in retinitis pigmentosa(1).
According to the Harvard Medical School, in the study of retinal degeneration in subgroups of patients with retinitis pigmentosa, suggested, diet rich in vitamin A and omega-3 fatty acids found abundantly in almond for at least 2 years, slowed the decline in visual field sensitivity(2).In a randomized, controlled, double-masked trial of 225 nonsmoking patients, aged 18 to 60 years conducted by the Harvard Medical School, said, "Lutein supplementation of 12 mg/d slowed loss of midperipheral visual field on average among nonsmoking adults with retinitis pigmentosa taking vitamin A"(3).

Green tea has been a precious drink in traditional Chinese culture and used exceptional in socialization for more than 4000 thousand years. Because of their health benefits, they have been cultivated for commercial purposes all over the world. Green tea extract is considered as one of most powerful antioxidant in common herbal supplement ameliorated the onset and progression of human RP through inhibited the photoreceptor apoptosis in animal model(4).
According to the study by the Evidence-Based Complementary and Alternative Medicine, catechin is a polyphenolic antioxidant commonly found in green tea, inhibited RP cell migration and adhesion, thereby providing potential preventive actions against Age-Related Macular Degeneration(AMD)(5).

Almond consists of an outer hull and a hard shell with the seed (nut) inside is native to the Middle East. It is most widely cultivated seed in the world for it economic and health benefit. Its phytochemical also exerted its antioxidant effect in inhibition of progression of retinitis pigmentos in many patients, according to the Harvard Medical School(6).
According to Dr. Hodge WG and colleagues at the University of Ottawa, in the review of 6 studies published between 1995 and 2004 met eligibility criteria, found that omega-3 fatty acids may slow the progression of retinitis pigmentosa, but definitive answers will require significantly more observational and interventional clinical research(7).

The combined green tea extract, vitamin A and omega 3 fatty acid found in green tea, carrot and almond respectively may contribute to further investigation of therapeutic natural ingredients for reduced risk and treatment of Retinitis pigmentosa.
People who are at increased risk of Retinitis pigmentosa due to aging or chronic illness should drink at least one serving daily and people with Retinitis pigmentosa should drink as much as they can, depending to digestive toleration.

References
(1) ω-3 intake and visual acuity in patients with retinitis pigmentosa receiving vitamin A by Berson EL1, Rosner B, Sandberg MA, Weigel-DiFranco C, Willett WC.(PubMed)
(2) Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses by Berson EL1, Rosner B, Sandberg MA, Weigel-DiFranco C, Moser A, Brockhurst RJ, Hayes KC, Johnson CA, Anderson EJ, Gaudio AR, Willett WC, Schaefer EJ.(PubMed)
(3) Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A by Berson EL1, Rosner B, Sandberg MA, Weigel-DiFranco C, Brockhurst RJ, Hayes KC, Johnson EJ, Anderson EJ, Johnson CA, Gaudio AR, Willett WC, Schaefer EJ.(PubMed)
(4) Green tea extract suppresses N-methyl-N-nitrosourea-induced photoreceptor apoptosis in Sprague-Dawley rats by Emoto Y1, Yoshizawa K, Kinoshita Y, Yuri T, Yuki M, Sayama K, Shikata N, Tsubura A.(PubMed)
(5) Botanical Compounds: Effects on Major Eye Diseases by Tuan-Phat Huynh,1,2,3 Shivani N. Mann,1,2 and Nawajes A. Mandal1,2,4,5(Hindawi Publishing Corporation)
(6) Retinitis pigmentosa by Hartong DT1, Berson EL, Dryja TP.(PubMed)
(7) The evidence for efficacy of omega-3 fatty acids in preventing or slowing the progression of retinitis pigmentosa: a systematic review by Hodge WG1, Barnes D, Schachter HM, Pan YI, Lowcock EC, Zhang L, Sampson M, Morrison A, Tran K, Miguelez M, Lewin G.(PubMed)

No comments:

Post a Comment